SavageD.G., RuleS.A.J., TigheM., GarrettT.J., OsterM.W., LeeR.T., RuizJ., HeitjanD., KeohanM.L., FlammM., JohnsonS.A.: Gemcitabine for relapsed or resistant lymphoma. Ann Oncol, 11: 595–597, 2000.
2.
MooreM.: Activity of gemcitabine in patients with advanced pancreatic carcinoma. Cancer, 78: 633–638, 1996.
3.
LüftnerD., FlathB., AkrivakisC., GrunewaldR., HergenthalerH.G., PossingerK.: Gemcitabine for palliative treatment in metastasic breast cancer. J Cancer Res Clin Oncol, 124: 527–531, 1998.
4.
KauffmannM., von MinckwitzG.: Gemcitabine in ovarian cancer: an overview of safety and efficacy. Eur J Cancer, 33: 31–33, 1997.
5.
MurrayN.: New drugs for small cell lung cancer. Oncology, 11: 38–42, 1997.
FossaA., SantoroA., HiddemannW., TruemperL., NiederleN., BuksmauiS., BonadonaG., SeeberS., NowrousianM.R.: Gemcitabine as a single agent in the treatment of the relapsed or refractory aggressive non-Hodgkin lymphoma. J Clin Oncol, 17: 3786–3792, 1999.
